Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Quadrivalent in influenza imprinted cohorts
NCT03686514Phase 4Terminated
- Sponsor
- Emory University
- Start
- Oct 2018
- Primary completion
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Influsplit in influenza, sponsored by Emory University. Started Oct 2018; status: terminated.
02
Drugs
Influsplit
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03686514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686514.